| Ms Bridget Anne Bidwell, PT | |
|
4 Executive Park Dr, Albany, NY 12203-3718 | |
| (518) 489-2449 | |
| (518) 489-2991 |
| Full Name | Ms Bridget Anne Bidwell |
|---|---|
| Gender | Female |
| Speciality | Physical Therapy |
| Experience | 24 Years |
| Location | 4 Executive Park Dr, Albany, New York |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1922075191 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 225100000X | Physical Therapist | 021228-1 (New York) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Prn Physical, Occupational And Speech Therapy Network, Pllc | 5092730788 | 72 |
News Archive
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M. Jankowski, PhD, FACSM, an exercise physiologist and associate professor at the University of Colorado College of Nursing at the Anschutz Medical Campus.
As the world is gripped with COVID-19 infection and fears of transmission, Southeast Asian nation India, being China's neighbor and the second most populous nation (with 1.3 billion population) in the world, is not spared.
Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.
At the request of the House Committee on Energy and Commerce as part of an investigation into preventable medical errors, the Institute of Medicine (IOM) has issued a report recommending further restrictions regarding duty hours for resident physicians and other actions to reduce resident fatigue and ensure patient safety, according to an article published in the January issue of the Journal of the American College of Radiology (JACR).
› Verified 7 days ago
| Provider Name | Prn Physical, Occupational And Speech Therapy Network, Pllc |
|---|---|
| Provider Type | Part B Supplier - Physical/occupational Therapy Group In Private Practice |
| Provider Identifiers | NPI Number: 1336185263 PECOS PAC ID: 5092730788 Enrollment ID: O20051012000029 |
News Archive
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M. Jankowski, PhD, FACSM, an exercise physiologist and associate professor at the University of Colorado College of Nursing at the Anschutz Medical Campus.
As the world is gripped with COVID-19 infection and fears of transmission, Southeast Asian nation India, being China's neighbor and the second most populous nation (with 1.3 billion population) in the world, is not spared.
Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.
At the request of the House Committee on Energy and Commerce as part of an investigation into preventable medical errors, the Institute of Medicine (IOM) has issued a report recommending further restrictions regarding duty hours for resident physicians and other actions to reduce resident fatigue and ensure patient safety, according to an article published in the January issue of the Journal of the American College of Radiology (JACR).
› Verified 7 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ms Bridget Anne Bidwell, PT 4 Executive Park Dr, Albany, NY 12203-3718 Ph: (518) 489-2449 | Ms Bridget Anne Bidwell, PT 4 Executive Park Dr, Albany, NY 12203-3718 Ph: (518) 489-2449 |
News Archive
Essentialis, Inc. announced today that the company has reached agreement with the U.S. Food and Drug Administration (FDA) on a Special Protocol Assessment (SPA) for a Phase 3 efficacy study required for product registration for its product candidate, Diazoxide Choline Controlled Release Tablet (DCCR), for the treatment of patients with very high triglycerides.
Women 55 and older have an increased risk of bone and muscle loss but therapy with the hormone Dehydroepiandrosterone may help prevent bone loss and increase muscle mass in older women, according to a new study led by Catherine M. Jankowski, PhD, FACSM, an exercise physiologist and associate professor at the University of Colorado College of Nursing at the Anschutz Medical Campus.
As the world is gripped with COVID-19 infection and fears of transmission, Southeast Asian nation India, being China's neighbor and the second most populous nation (with 1.3 billion population) in the world, is not spared.
Capstone Therapeutics announced today that participating subjects have reached the planned twelve-month timepoint in the first of its two ongoing AZX100 Phase 2a clinical trials in keloid scarring. Data analysis for these subjects is underway. Per protocol and the original clinical development plan, results of the two keloid scarring trials will be pooled for analytical purposes and are scheduled for release during 4Q2010.
At the request of the House Committee on Energy and Commerce as part of an investigation into preventable medical errors, the Institute of Medicine (IOM) has issued a report recommending further restrictions regarding duty hours for resident physicians and other actions to reduce resident fatigue and ensure patient safety, according to an article published in the January issue of the Journal of the American College of Radiology (JACR).
› Verified 7 days ago
Jordan Iris Bakowski, PT, DPT Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 900 Watervliet Shaker Rd, Suite 102, Albany, NY 12205 Phone: 518-862-4900 | |
Yuan Kenneth Jin, DPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Ste 200, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Penelope M Blasch, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Heather M. Lacasse, MPT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 121 Everett Rd Health Park, Albany, NY 12205 Phone: 518-489-2524 Fax: 518-489-3167 | |
Marianna Vaysman, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 281 Sand Creek Rd, Albany, NY 12205 Phone: 518-459-1292 Fax: 518-459-1296 | |
Kimberly Silvernail Keane, PT Physical Therapist Medicare: Accepting Medicare Assignments Practice Location: 314 S Manning Blvd, Albany, NY 12208 Phone: 518-453-2273 | |
Dr. Janel Lena Carver, D.P.T. Physical Therapist Medicare: Not Enrolled in Medicare Practice Location: 80 Clinton Ave Apt 1, Albany, NY 12210 Phone: 914-299-9514 |